Meet De Clercq & Partners at BIO-Europe 2024 in Stockholm!
  • General

Meet De Clercq & Partners at BIO-Europe 2024 in Stockholm!

Read more | Meet De Clercq & Partners at BIO-Europe 2024 in Stockholm!
Timeline of Infringement and Revocation Actions Before the Unified Patent Court (UPC)
  • IP news
  • UP & UPC
  • Patents

Timeline of Infringement and Revocation Actions Before the Unified Patent Court (UPC)

Read more | Timeline of Infringement and Revocation Actions Before the Unified Patent Court (UPC)
Use of an infant formula for promoting growth is not a method of treatment by therapy
  • IP news
  • Patents

Use of an infant formula for promoting growth is not a method of treatment by therapy

Read more | Use of an infant formula for promoting growth is not a method of treatment by therapy
T2360/19 reasoning confirms the impact of G1/22 and G2/22 on formal priority in the Broad, MIT and Harvard CRISPR cases
  • Patents
  • IP news

T2360/19 reasoning confirms the impact of G1/22 and G2/22 on formal priority in the Broad, MIT and Harvard CRISPR cases

Read more | T2360/19 reasoning confirms the impact of G1/22 and G2/22 on formal priority in the Broad, MIT and Harvard CRISPR cases
Koen Vanhalst Named One of the World's Leading IP Strategists for 2024 by IAM Strategy 300
  • General

Koen Vanhalst Named One of the World's Leading IP Strategists for 2024 by IAM Strategy 300

Read more | Koen Vanhalst Named One of the World's Leading IP Strategists for 2024 by IAM Strategy 300
G 1/24 : Enlarged Board of Appeal referral on claim interpretation
  • Patents
  • IP news

G 1/24 : Enlarged Board of Appeal referral on claim interpretation

Read more | G 1/24 : Enlarged Board of Appeal referral on claim interpretation
Ambush Marketing: How organizers rein in free riding on sports’ appeal
  • Trademarks
  • IP news

Ambush Marketing: How organizers rein in free riding on sports’ appeal

Read more | Ambush Marketing: How organizers rein in free riding on sports’ appeal
Read Our Latest Newsletter!

Read Our Latest Newsletter!

Read more | Read Our Latest Newsletter!
De Clercq & Partners, Belgium Achieves Top Tier Firm Ranking in IP STARS
  • General

De Clercq & Partners, Belgium Achieves Top Tier Firm Ranking in IP STARS

Read more | De Clercq & Partners, Belgium Achieves Top Tier Firm Ranking in IP STARS
De Clercq & Partners has won the Jurisdiction Award for the Benelux at the European Women in Business Law Awards 2024!
  • General

De Clercq & Partners has won the Jurisdiction Award for the Benelux at the European Women in Business Law Awards 2024!

Read more | De Clercq & Partners has won the Jurisdiction Award for the Benelux at the European Women in Business Law Awards 2024!
The impact of G1/22 and G2/22 on formal priority attacks by Opponents
  • Patents
  • IP news

The impact of G1/22 and G2/22 on formal priority attacks by Opponents

Read more | The impact of G1/22 and G2/22 on formal priority attacks by Opponents
Unitary Patents – A Numerical Journey in the European Patent Landscape
  • IP news
  • UP & UPC
  • Patents

Unitary Patents – A Numerical Journey in the European Patent Landscape

Read more | Unitary Patents – A Numerical Journey in the European Patent Landscape
Broader definition of “substance or composition” in medical use claims
  • IP news
  • Patents

Broader definition of “substance or composition” in medical use claims

Read more | Broader definition of “substance or composition” in medical use claims
Congratulations to Giel Vandemoortele on Becoming a Qualified Belgian Patent Attorney
  • General
  • Patents

Congratulations to Giel Vandemoortele on Becoming a Qualified Belgian Patent Attorney

Read more | Congratulations to Giel Vandemoortele on Becoming a Qualified Belgian Patent Attorney
Rejections of Requests for Unitary Effect – an update
  • IP news
  • UP & UPC

Rejections of Requests for Unitary Effect – an update

Read more | Rejections of Requests for Unitary Effect – an update
Romania Joins the UPCA
  • IP news
  • UP & UPC
  • Patents

Romania Joins the UPCA

Read more | Romania Joins the UPCA